Related Experiment Video
Updated: Jul 14, 2026

Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation
Published on: January 12, 2016
Alterations in the hemodynamic response function in cognitively impaired HIV/AIDS subjects
Shannon B Juengst1, Howard J Aizenstein, Jennifer Figurski
1Department of Psychiatry, University of Pittsburgh School of Medicine, United States. juengstsb@upmc.edu <juengstsb@upmc.edu>
Functional MRI (fMRI) reveals subtle brain changes in HIV/AIDS patients with cognitive impairment. The blood oxygen level dependent hemodynamic response function (BOLD HRF) in impaired individuals showed delayed return to baseline, impacting fMRI study reliability.
Area of Science:
- Neuroimaging
- Neuroscience
- Infectious Diseases
Background:
- Functional magnetic resonance imaging (fMRI) is crucial for understanding Central Nervous System (CNS) alterations in HIV/AIDS.
- Assessing the blood oxygen level dependent hemodynamic response function (BOLD HRF) is a prerequisite for advanced cognitive fMRI studies in this population.
Purpose of the Study:
- To compare BOLD HRF signals between HIV/AIDS patients and control subjects.
- To establish the BOLD HRF as a baseline measure for cognitive function studies in HIV/AIDS.
Main Methods:
- Event-related fMRI was employed to measure BOLD HRF in the precentral gyrus during a sensory-motor task.
- Subjects were categorized into control, Normal/Asymptomatic Neuropsychological Impairment (ANI), and Minor Neurocognitive Disorder (MNCD)/HIV-Associated Dementia (HAD) groups.
Main Results:
- No significant differences in BOLD HRF were observed based on age, hemisphere, or HIV serostatus alone.
- MNCD/HAD subjects exhibited a BOLD HRF that did not return to baseline within 16 seconds.
- This prolonged HRF in MNCD/HAD subjects suggests potential alterations in neuronal function.
Conclusions:
- Subtle alterations in neuronal function, indicated by prolonged BOLD HRF, are present in HIV/AIDS patients with significant cognitive impairment (MNCD/HAD).
- These findings highlight potential challenges for event-related fMRI studies in this specific patient subgroup.
- Further research is needed to understand the full implications of these neurophysiological changes for cognitive assessment using fMRI.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Encephalopathy
Pharmacodynamics in Geriatric Patients: Effects of Age

